PATENT CLAIM ANALYSIS

Application Number: 15976012
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "280000"]

Abstract:
The invention relates to a novel approach to the treatment of autoimmune diseases, particularly multiple sclerosis. In a further embodiment of the invention there is provided a molecule capable of acting as substrate for the queuine-insertase enzyme complex and where said molecule is not a substrate for Hypoxanthine-guanine phosphoribosyltransferase and said molecule has the effect of lowering interferon gamma, for use in the treatment of auto-immune diseases. Preferably the autoimmune disease is multiple sclerosis.

Claim (Index 13):
A method comprising contacting a mammalian cell with a molecule acting as a substrate for an queuine-insertase enzyme complex to reduce or inhibit endogenous cellular mechanism(s) in the mammalian cell associated with an autoimmune disease.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.64583
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15087807', '15087811', '15539519', '13256345', '15751782']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6889187925680655
- 35 USC 102 Novelty (BERT): 0.493736901389058
- Combined Prediction Score: 0.6694006034501648
- Mean Citation Score: 163.07404
- Max Citation Score: 166.72618
- Similarity Product: 106.0560624645686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test